Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Cytarabine in Pediatric ALL with CNS Involvement
NCT01593488Phase 2Unknown
- Sponsor
- National Cancer Institute
- Start
- Mar 2012
- Primary completion
- Dec 2024
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal cytarabine in acute lymphoblastic leukemia (ALL), sponsored by National Cancer Institute. Status: unknown.
02
Drugs
liposomal cytarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01593488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01593488.